TickerFacts.

ImageneBio, Inc. (IMA): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$400.0K
Year ended 2025-12-31
$1.10M2024-12-31: $1.10M2025-12-31: $400.0K$400.0K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$400.0K-63.6%2026-03-10, From 2025-01-01
2024-12-31$1.10Mn/a2026-03-10, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
ImageneBio, Inc. (IMA)2025-12-31$400.0K-63.6%
Prokidney Corp. (PROK)2025-12-31$6.58M+21.0%
Pluri Inc. (PLUR)2026-06-30$511.0K+61.7%
Cardiff Oncology, Inc. (CRDF)2025-12-31$364.0K-9.9%
Inhibrx Biosciences, Inc. (INBX)2025-12-31$2.48M+8.7%
Scinai Immunotherapeutics Ltd. (SCNI)2025-12-31$1.42M-13.8%
Outlook Therapeutics, Inc. (OTLK)2025-09-30$117.1K+2.8%
aTYR PHARMA INC (ATYR)2025-12-31$664.0K-6.2%
Surrozen, Inc. (SRZN)2025-12-31$537.0K-62.8%

Compare IMA, PROK, PLUR, CRDF side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗